title: Treatment of persistent chylothorax with somatostatin.
authors.forename: Takehiko
authors.initials: T
authors.lastname: Matsuo
authors.forename: Masahiko
authors.initials: M
authors.lastname: Matsumoto
authors.forename: Takaaki
authors.initials: T
authors.lastname: Sugita
authors.forename: Junichiro
authors.initials: J
authors.lastname: Nishizawa
authors.forename: Katsuhiko
authors.initials: K
authors.lastname: Matsuyama
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Tokuda
authors.forename: Kazunori
authors.initials: K
authors.lastname: Yoshida
mesh_terms: D000015:Abnormalities, Multiple / Q000175:diagnosis / Q000601:surgery*; D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D007415:Intestinal Obstruction / Q000139:chemically induced* / Q000601:surgery; D011379:Prognosis; D011651:Pulmonary Artery / Q000002:abnormalities / Q000601:surgery; D011667:Pulmonary Veins / Q000002:abnormalities / Q000601:surgery; D012008:Recurrence; D018570:Risk Assessment; D013004:Somatostatin / Q000008:administration & dosage / Q000009:adverse effects*; D013154:Spleen / Q000002:abnormalities; D019616:Thoracic Surgical Procedures / Q000009:adverse effects* / Q000379:methods
chemical_list: D013004:Somatostatin